Endoscopic mesorectal dissection for precise pathologic staging and potential treatment of locally advanced rectal cancer

内镜下直肠系膜切除术用于精确的病理分期和局部晚期直肠癌的潜在治疗

阅读:1

Abstract

BACKGROUND AND AIMS: Traditional surgical techniques for rectal cancer resection may face limitations in accessing lesions at extreme rectal locations. Endoscopic mesorectal dissection (EMD) enables wide-margin resection without the constraints of conventional surgery. We present a case demonstrating the feasibility of EMD for accurate, organ-sparing staging of rectal cancer. A 67-year-old man with abdominal pain and positive Cologuard test (Exact Sciences Corporation, Madison, Wis, USA) results underwent colonoscopy that revealed a 2-cm sessile polyp 12 cm from the anal verge, removed with a hot snare. Pathology showed invasive adenocarcinoma with positive deep margins. Given challenges with low anterior resection and transanal total mesorectal excision, EMD was selected for precise staging. METHODS: Endoscopy revealed a 15-mm postpolypectomy scar with nodularity. Lesion borders were marked, and methylene blue injection achieved partial lift. A circumferential incision exposed the muscularis propria, allowing full-thickness myotomy into the perirectal fat. The 35-mm lesion was dissected and retrieved en bloc, and the defect was closed with OverStitch sutures (Boston Scientific Corporation, Marlborough, Mass, USA). RESULTS: Pathology confirmed pT2 adenocarcinoma with R0 margins. The patient had no adverse events, demonstrating the technical success of EMD in achieving en bloc R0 resection. CONCLUSIONS: EMD achieved en bloc R0 resection, highlighting its efficacy as a minimally invasive, organ-sparing approach for precise staging of rectal cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。